NIH Regenerative Medicine Innovation Project (RMIP)
2018 RMIP Funding Opportunity Announcements
- Title: RMIP Investigator-Initiated Research Project
- ID Number: RFA-HL-18-030
- Activity Code: U01 - Clinical Trial Not Allowed
- Earliest Submission Date: September 19, 2018
- Application Due Date: October 19, 2018
- Title: RMIP Investigator-Initiated Clinical Trials
- ID Number: RFA-HL-18-031
- Activity Code: UG3/UH3 - Clinical Trial Required
- Earliest Submission Date: September 19, 2018
- Application Due Date: October 19, 2018
- Title: RMIP Small Business Technology Transfer Cooperative Agreement
- ID Number: RFA-HL-18-033
- Activity Code: UT2 - Clinical Trial Not Allowed
- Earliest Submission Date: September 19, 2018
- Application Due Date: October 19, 2018
- Title: RMIP Small Business Innovation Research Cooperative Agreement
- ID Number: RFA-HL-18-035
- Activity Code: U44 - Clinical Trial Not Allowed
- Earliest Submission Date: September 19, 2018
- Application Due Date: October 19, 2018
NHLBI Funding Opportunities
- RFA-HL-17-015 Bold New Bioengineering Methods and Approaches for Heart, Lung, Blood and Sleep Disorders and Diseases (R21)
- PAR-18-683 NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required)
NIH Funding Opportunities
- PAR-16-369 Resource-Related Research Projects for Development of Animal Models and Related Materials (R24)
- PAR-16-322 Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24)
NINDS Funding Opportunities
- PAR-17-456 CREATE Bio Optimization Track for Biologics (U01)
- PAR-17-457 CREATE Bio Optimization Track for Biologics (SBIR-U44)
- PAR-18-542 CREATE Bio Development Track: Nonclinical and Early-Phase Clinical Development for Biologics (U01 Clinical Trial Optional)
- PAR-18-543 CREATE Bio Development Track: Nonclinical and Early-Phase Clinical Development for Biologics (U44 Clinical Trial Optional)
Vertical Tabs
This page is associated with a larger collection of pages. You can view them as a whole here.